Biogen Inc (NASDAQ:BIIB) has received an “A” credit rating from analysts at Morningstar. The firm’s “A” rating suggests that the company is a low default risk. They also gave their stock a five star rating. In related news, CMO Alfred Sandrock sold 441 shares of the company’s stock in a transaction on Friday, December 4th. […]
